CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT

CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[(METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO]-4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE OR COBICISTAT

The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DE ARMAS, HECTOR NOVOA, YU, RICHARD HUNG CHIU, LAI, CHIAJEN, YU, LOK HIM LAWRENCE
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia).